| Preliminary Scientific Programme |
| SATURDAY | SUNDAY | MONDAY | TUESDAY | WEDNESDAY |
| Monday, 12 June 2006 |
08.30 – 10.15
Room: Hall B Chairpersons: Burden of childhood allergies Challenge of allergy prevention in children Challenge of treating allergies in children:
the effects of latest generation antihistamines Challenge of managing allergies in children:
safety first
Room: Hall A Chairpersons: Is air pollution important in asthma? Thunderstorm-induced asthma in pollinosis patients Air pollution: only trigger or also sensitiser? PPP: Pollen, Pollution and Proteomics
Room: Hall C Chairpersons: Does it work, do we need it? Management of Aspirin-sensitive rhinosinusitis
/ asthma syndrome: what role for Aspirin desensitisation Tolerance induction to antibiotics Tolerance induction to antiretroviral drugs
- a need for protocols
Room: Hall D Chairpersons: Neurotrophins in allergy Neurotrophins in human airways Melancortins and their receptors in human mast
cells and basophils: Implications for neuroimmunology and allergology Tachykinins and their role in allergic inflammation
4: How to Prevent Anaphylaxis in Children 5: Problems and Pitfalls in Allergy Diagnosis 6. What you Want to Know about Microarray Technology
Room: Hall F Chairpersons: Preventive measures Childhood asthma Diagnosis of asthma Therapy of asthma
Room: Hall E2 Chairperson: Immunoregulation of allergy Allergen-specific immunotherapy of allergy Allergy in the lung Dermatoallergology Room: Hall M Chairpersons: Introductory lecture: Monitoring Hymenoptera
venom immunotherapy
Room: Hall N Chairpersons: Introductory lecture: The hygiene hypothesis:
Current status and future perspective 10.30-12.15 Room: A Chairpersons: Dendritic cells as modulators of the allergic
response B cells: From IgE production to antigen presentation T cells as regulators and effectors Human mast cells and basophils: only classical
effectors? 12.15 – 13.30 EAACI General Assembly & Council of National Societies The General Assembly is the governing body of the Academy. EAACI members are encouraged to actively participate in this meeting and present their views. We encourage members to arrive on time as we will begin promptly at 12.15 on Monday 12 June in Hall C at the Austria Center Vienna. Please bring your EAACI membership card with you to gain entry to this meeting. If you have forgotten your membership card then please go to the EAACI stand in the Registration area to receive a replacement. Replacement cards can be given out from Saturday 09.00 until Monday 11.00 at the latest. Lunch boxes will be provided at this meeting. 13.30 – 15.15 Room: Hall B Chairpersons: Which is more effective for controlling mild
to moderate persistent asthma: ICS monotherapy or ICS LABA combination
therapies? Do safety concerns limit your ability to maximize
the dose of ICS to manage symptoms and underlying inflammation? Does convenience of dosing and patient adherence
influence your design of treatment plans for individual patients? How do you motivate patients to improve adherence
to treatment plans? Room: Hall A Chairpersons: Translating innate into adaptive immunity Pollen-derived signals modulate innate immunity Mast cells in the innate immune response NK cells: friend or foe in allergy? Room: Hall F Chairpersons: Histamine Type 2 receptor in protection mechanisms
against venom hypersensitivity Double positivity to honey bee and vespula
venom: crossreactivity or true double sensitization? How useful is the tryptase measurement - lessons
from the European Multicenter Study Occupation venom allergy: a) in bee keepers
b) in green house workers
Room: Hall G Chairperson: The spectrum of mediterranean plant allergens Tree and grass pollen allergens Biology of house dust mite allergens Allergens from animals: Focus on cat
Room: Hall H Chairpersons: Study design of ongoing birth cohort studies A review of major results from ongoing birth
cohort studies A review of major results from ongoing interventional
birth cohort studies New perspectives, where do we go from now?
Room: Hall I Chairpersons: Predictive value of autoantibody determination Immunologic hypersensitivity reactions in patients
with silicone implants The value of immunofluorescence for the diagnosis
of autoimmune disease with special emphasis on tissue microarrays New optical methods for the diagnosis of immunologic
diseases Room: Hall D Chairpersons: Internet in allergology, how to better communicate
with people From molecule structure to allergen nomenclature Computational and experimental approach to
allergenicity From in silico to reality and back
Room: Hall K Chairpersons: Pathology and immunohistochemistry in systemic
mastocytosis c-KIT mutations in mastocytosis: current status The impact of flow cytometric analysis in
the diagnosis, follow-up and monitoring of therapy in mastocytosis WHO classification of mastocytosis and treatment
options New therapies and targeted drugs for systemic
mastocytosis
Room: Hall E2 Chairpersons: Animal models for autoimmune blistering diseases Novel mouse models for combined immunodeficiency Mouse models of atopic eczema Mouse models of allergic asthma
Room: Hall M Chairpersons:
Room: Hall N Chairpersons: Introductory lecture: Problems and pitfalls
in the diagnosis of drug hypersensitivity 15.30 – 17.15 Room: Hall B Chairpersons: Allergen exposure and the epidemiologic of
allergy Mucosal and systemic immune response to allergen
challenge The new evidence for allergen immunotherapy A tablet for the future treatment for grass
allergy
Room: Hall C Chairperson: Regulatory T cell therapy in allergy and asthma Generation of therapeutic regulatory T cells Dendritic cell subsets Dendritic cell therapy
Room: Hall G Chairpersons: How allergens enter the body Pollen induced asthma Tracing allergens by electron microscopy Lessons from measuring allergens in our environment Room: Hall D Chairpersons: Influence of the Chernobil disaster on the
incidence of atopy Viral infection and asthma Platelets and asthma Sputum assessments in asthma New assessments of venom desensitisation Allergy considerations Asthma and urinary sediment
Room: Hall H Chairpersons: Mechanisms of mucus induction in allergic inflammation
in asthma Mechanisms of virus induction of mucus in asthma
exacerbations Inhibition of airway mucus hypersecretion in
asthma Is mucus synthesis and secretion a valid therapeutic
target in asthma therapy? Room: Hall I Chairpersons: Chairmen's introduction Mannose binding lectin deficiency Defects in antigen presentation B cell memory and antibody deficiency
Room: Hall K Chairpersons: Dendritic cell vaccines Artificial antigen-presenting cells/platforms Oligonucleotides for inducing potent immune
responses Exosomes - naturally occurring minimal antigen
presenting units
Room: Hall E2 Chairpersons: Alternative therapies for rhinitis and rhinosinusitis
Gastroesophageal reflux and rhinosinusitis
Room: Hall L Chairpersons:
Room: Hall M Chairpersons:
Room: Hall N Chairpersons: Introductory lecture: Where are we with the
new strategies for Allergy 17.30 – 19.15
Room: Hall B Chairperson: Phase I – Safety data Phase IIb/III – Clinical data Perspectives
Room: Hall G Chairperson: Modified extracts for allergen specific immunotherapy Allergoids in clinical trials Major Allergens: the quality of allergenic
extracts New biomarkers for efficacy monitoring of SIT
Room: Hall D Chairpersons: IgE and its receptors: Effector cell activation: Regulatory T cell networks Murine models:
Room: Hall L Chairpersons:
Room: Hall M Chairpersons: Room: Hall N Chairpersons:
Room: Hall O Chairpersons: |